Paul K.J.D. de Jonge

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Jolien M.R. Van der Meer et al. · OncoImmunology · 2020 · 65 citations · Full text

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall et al. · Cancer Immunology Immunotherapy · 2020 · 43 citations · Full text

Vivo Half-life, Immunology, Immune Regulation +21

Visualisation of newly synthesised collagen in vitro and in vivo

Corien Oostendorp, Peter J.E. Uijtdewilligen, Elly M. M. Versteeg et al. · Scientific Reports · 2016 · 26 citations · Full text

Bladder Regeneration Using Multiple Acellular Scaffolds with Growth Factors in a Bladder

L.A.J. Roelofs, Paul K.J.D. de Jonge, Egbert Oosterwijk et al. · Tissue Engineering Part A · 2017 · 22 citations

CD34 ⁺ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg ^null mice

Jolien M.R. Van der Meer, Paul K.J.D. de Jonge, Anniek B. van der Waart et al. · OncoImmunology · 2021 · 19 citations · Full text